Viewing Study NCT00319306


Ignite Creation Date: 2025-12-26 @ 1:17 PM
Ignite Modification Date: 2025-12-29 @ 3:54 PM
Study NCT ID: NCT00319306
Status: COMPLETED
Last Update Posted: 2009-03-17
First Post: 2006-04-27
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Real Life Effectiveness in Asthma of Symbicort Single Inhaler Therapy
Sponsor: AstraZeneca
Organization:

Study Overview

Official Title: Real Life Effectiveness in Asthma of Symbicort Single Inhaler Therapy
Status: COMPLETED
Status Verified Date: 2009-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: RELEASE
Brief Summary: The purpose of this study is to determine whether patients with asthma are better able to manage and control their symptoms by using one inhaler daily that both prevents as well as treats the symptoms of an asthma exacerbation.
Detailed Description: None

Study Oversight

Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
RELEASE None None View